$10.56 -0.35 (-3.21%) Omeros Corp - NASDAQ

Dec. 5, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 10.56
Trade Time: Dec 05 04:00 PM Eastern Daylight Time
Change: -0.35 (-3.21%)
Prev Close: 10.91
Open: 11.10
Bid: 10.54
Ask: 10.55
  1. Omeros Announces OMIDRIAssureā„¢ to Expand Patient Access to OmidriaĀ®

    Benzinga | Oct. 15, 2015 | 06:02AM EST
  2. Where Is Omeros Corporation Now?

    Benzinga | Aug. 26, 2015 | 13:55PM EST
  3. Omeros Corporation: Another Biotech Bubble In The Making?

    Benzinga | Aug. 18, 2015 | 13:19PM EST
  4. Mid-Day Market Update: Tuesday's Top 10 Volume Stocks

    Benzinga | Aug. 18, 2015 | 11:59AM EST
  5. Mid-Day Market Update: National Penn Bancshares Surges On Acquisition News; Vera Bradley Shares Slide

    Benzinga | Aug. 18, 2015 | 11:47AM EST
  6. Mid-Day Market Update: Tuesday's Movers, China's Growth Worries And More

    Benzinga | Aug. 18, 2015 | 10:59AM EST
  7. Mid-Morning Market Update: Markets Open Lower; Wal-Mart Lowers Full-Year Forecast

    Benzinga | Aug. 18, 2015 | 09:32AM EST
  8. Benzinga's Volume Movers

    Benzinga | Aug. 18, 2015 | 09:31AM EST
  9. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 18, 2015 | 07:15AM EST
  10. Benzinga's Top Initiations

    Benzinga | Aug. 10, 2015 | 09:00AM EST
  11. Omeros Announces FDA Grants Fast Track Designation to Complement Inhibitor OMS721 for aHUS

    Benzinga | Jul. 23, 2015 | 06:09AM EST
  12. Omidria Receives Positive Opinion from European Medicines Agency's Committee for Medicinal Products for Human Use

    Benzinga | May. 22, 2015 | 06:01AM EST
  13. Benzinga's Volume Movers

    Benzinga | Mar. 2, 2015 | 10:39AM EST
  14. Wedbush Highlights 2015 Catalysts for Emerging BioPharmaceuticals

    GuruFocus | Feb. 4, 2015 | 13:43PM EST
  15. Omeros Reports OMS721 Inhibits Thrombus Formation in Sera from aHUS Patients

    Benzinga | Nov. 19, 2014 | 07:21AM EST
Trading Center